Results 1 -
10
of
70
for
Breast plasma
- ... by multiple myeloma (cancer that begins in the plasma cells [a type of white blood cell that produces substances needed to fight infection]) or by breast cancer that has spread to the bones. Pamidronate ...
- ... loss, to treat bone loss in women with breast cancer who are receiving certain ... that begins in the plasma cells and causes bone damage), and in people ...
- ... blood sugar while the infant is being fed breast milk or a formula containing lactose In many states, newborn screening tests check for galactosemia. Test results may show: Amino acids in the urine or blood plasma Enlarged liver Fluid in the abdomen Low blood ...
- MedWatch, the FDA Safety Information and Adverse Event Reporting Program (Food and Drug Administration)Medical Device Safety/Related Issues ... Medical Device Safety ... Drug Reactions/Related Issues ... Drug Reactions ... Drug Safety/Related Issues ... Drug Safety ... Food and Drug ...
- Vitamin D (Harvard School of Public Health)Vitamin D Deficiency/Learn More ... Vitamin D Deficiency ... Harvard School of Public Health ... Vitamin D is both a nutrient we eat and a hormone our bodies make. It ...
- Treatment of plasma cell neoplasms (including multiple myeloma, monoclonal gammopathy of undetermined significance, and plasmacytoma) includes observation, ...
- General Information about Plasma Cell Neoplasms (Including Multiple Myeloma)
(National Cancer Institute)
Multiple Myeloma/Start Here ... Multiple Myeloma ... Amyloidosis/Related Issues ... Amyloidosis ... National Cancer Institute ... Treatment of plasma cell neoplasms (including ... - Multiple Myeloma/Diagnosis and Tests ... Multiple Myeloma ... National Cancer Institute ... From the National Institutes of Health ... Treatment of plasma cell neoplasms ( ...
- ... from other areas of the body. Prostate , lung , breast , thyroid , ... that starts in the plasma cells of the bone marrow The cause of ...
- ... could cause other serious complications) in combination with plasma exchange therapy and immunosuppressant medications. Caplacizumab-yhdp is ... an intravenous injection at least 15 minutes before plasma exchange, and then again as a subcutaneous injection ...